[HTML][HTML] Romidepsin for the treatment of relapsed/refractory peripheral T cell lymphoma: prolonged stable disease provides clinical benefits for patients in the pivotal …
Background Achievement of durable responses in patients with relapsed/refractory
peripheral T cell lymphoma (PTCL) is challenging with current therapies, and there are few …
peripheral T cell lymphoma (PTCL) is challenging with current therapies, and there are few …
Responses to romidepsin by line of therapy in patients with relapsed or refractory peripheral T‐cell lymphoma
F Foss, B Pro, H Miles Prince, L Sokol… - Cancer …, 2017 - Wiley Online Library
Peripheral T‐cell lymphoma (PTCL) is a heterogeneous group of aggressive non‐Hodgkin
lymphomas typically associated with poor prognosis. Most patients with PTCL receive …
lymphomas typically associated with poor prognosis. Most patients with PTCL receive …
[PDF][PDF] Let us know how access to this document benefits yo u
MF Lembo - Science, 2006 - core.ac.uk
Circadian clocks are endogenous timekeeping mechanisms, which give the sense of time-of-
day to most organisms. To help the organisms to adapt to daily fluctuations in the …
day to most organisms. To help the organisms to adapt to daily fluctuations in the …